Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs? [electronic resource]
Producer: 20070918Description: 151-3 p. digitalISSN:- 1479-1641
- Animals
- Anti-Obesity Agents -- pharmacology
- Diabetes Mellitus, Type 2 -- drug therapy
- Disease Models, Animal
- Gastric Bypass
- Gastric Inhibitory Polypeptide -- deficiency
- Humans
- Hypoglycemic Agents -- pharmacology
- Insulin Resistance
- Insulin-Secreting Cells -- metabolism
- Obesity -- complications
- Receptors, Gastrointestinal Hormone -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.